Oslo, 22 September 2026 - Observe Medical ASA (the "Company" or "Observe
Medical") today announces the launch of its new website, designed to create a
direct, responsive dialogue with healthcare decision-makers about UnoMeterT
SafetiT Max, an innovative solution with the potential to deliver clear clinical
and health-economic advantages.
The new digital platform provides healthcare leaders, decision-makers,
clinicians and other stakeholders with accessible information about UnoMeterT
SafetiT Max and the rest of the Company's portfolio, its clinical evidence
and its contribution to more efficient and sustainable healthcare.
"Healthcare decision-makers need clear, evidence-based information that
demonstrates both patient value and the broader impact on healthcare systems,"
said Jørgen Mann, CEO at Observe Medical. "With our new website, we want to make
it easier to engage directly with those responsible for healthcare decisions and
have a constructive dialogue about how UnoMeterT SafetiT Max can address
important clinical and health-economic needs."
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available atwww.observemedical.com.
.\
\
Further information is available atwww.observemedical.com.\